• Mallinckrodt and FTC Resolve Questcor Matter americanpharmaceuticalreview
    January 20, 2017
    Mallinckrodt announced that it has reached agreement with the U.S. Federal Trade Commission (FTC) to resolve, without admission of wrongdoing, the previously disclosed FTC investigation into the acquisition by Questcor Pharmaceuticals, Inc., of Synacthen®
PharmaSources Customer Service